Assessment of Quitting versus Using Aspirin Therapy In Patients with Stabilized Coronary Artery Disease after Stenting who Require Long-term Oral Anticoagulation: The AQUATIC Trial
The AQUATIC trial demonstrated that among patients with an indication for oral anticoagulation (OAC) and prior coronary stent implantation, the addition of aspirin to OAC significantly increased the risk of the primary outcome (cardiovascular death, MI, stroke, systemic embolism, coronary revascularization, and acute limb ischemia [ALI]), major bleeding, and all-cause mortality, according to a study presented by Dr. Martine Gilard, Brest University, France, in the Hot Line session at ESC Congress 2025.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations
